CRIS Current Research Information System

DE MARCO, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.830
EU - Europa 2.141
AS - Asia 1.116
AF - Africa 211
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.308
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.816
GB - Regno Unito 625
IT - Italia 599
CN - Cina 464
SG - Singapore 257
DE - Germania 250
VN - Vietnam 206
SE - Svezia 140
IN - India 103
RU - Federazione Russa 93
UA - Ucraina 93
TG - Togo 90
IE - Irlanda 89
FR - Francia 80
EE - Estonia 52
ZA - Sudafrica 52
CI - Costa d'Avorio 41
BG - Bulgaria 38
JO - Giordania 25
NG - Nigeria 22
CH - Svizzera 17
HK - Hong Kong 16
BE - Belgio 12
CA - Canada 12
HR - Croazia 11
FI - Finlandia 10
ES - Italia 8
ID - Indonesia 8
CL - Cile 7
IR - Iran 7
JP - Giappone 7
LB - Libano 7
RO - Romania 7
AT - Austria 6
SC - Seychelles 6
TR - Turchia 6
PK - Pakistan 4
NL - Olanda 3
GR - Grecia 2
IL - Israele 2
MX - Messico 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CZ - Repubblica Ceca 1
EU - Europa 1
HU - Ungheria 1
LK - Sri Lanka 1
MK - Macedonia 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.308
Salva come PNG Salva come JPEG
Città #
Southend 543
Fairfield 375
Chandler 254
Ashburn 234
Singapore 220
Woodbridge 190
Seattle 162
Santa Clara 159
Wilmington 154
Bologna 151
Cambridge 149
Ann Arbor 133
Princeton 129
Houston 124
Dong Ket 107
Lomé 90
Dublin 85
Nanjing 77
Boardman 71
Westminster 59
Padova 55
Jacksonville 49
Jinan 49
Abidjan 41
Berlin 41
Sofia 38
Beijing 37
Saint Petersburg 36
Shenyang 33
Hebei 29
Bremen 28
Amman 25
Medford 23
Abeokuta 22
Changsha 22
Redmond 21
San Diego 20
Milan 18
Tianjin 17
Guangzhou 16
Turin 15
Shanghai 14
Forlimpopoli 12
Hangzhou 11
Nanchang 11
Zhengzhou 11
Haikou 10
Helsinki 10
Mülheim 10
Redwood City 10
Falls Church 9
Hong Kong 9
Jiaxing 9
Norwalk 9
Brussels 8
Dearborn 8
Des Moines 8
Los Angeles 8
New York 8
Ningbo 8
Shenzhen 8
Zurich 8
Ravenna 7
Jakarta 6
London 6
Moscow 6
Olalla 6
Taiyuan 6
Taizhou 6
Fremont 5
Lanzhou 5
Luisago 5
Mahé 5
Modena 5
Parma 5
San Venanzo 5
Toronto 5
Wuhan 5
Antwerp 4
Caserta 4
Costa Mesa 4
Florence 4
Istanbul 4
Lausanne 4
Mordano 4
Rome 4
Santiago 4
Scuola 4
Shijiazhuang 4
Velletri 4
Venezia 4
Verona 4
Ascoli Piceno 3
Chengdu 3
Chongqing 3
Fuzhou 3
Gainesville 3
Göttingen 3
Imola 3
Ivrea 3
Totale 4.468
Salva come PNG Salva come JPEG
Nome #
A simple route towards peptide analogues containing substituted (S)- or (R)-tryptophans 170
A novel family of minimalist opioid peptides deprived of the classic pharmacophores 167
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 166
Modern tools for the chemical ligation and synthesis of modified peptides and proteins 164
5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists 163
Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization 149
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 147
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES 144
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 143
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics 139
Analytical pyrolysis of dipeptides containing proline and amino acids with polar side chains. Novel 2,5-diketopiperazine markers in the pyrolysates of proteins 134
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 131
Diagnostic implementation of fast and selective integrin-mediated adhesion of cancer cells on functionalized zeolite L monolayers 129
DESIGN AND SYNTHESIS OF OPIOID PEPTIDE ANALOGUES AND MIMETICS 129
Controlling Cyclopeptide Backbone Conformation with β/α-Hybrid Peptide–Heterocycle Scaffolds 129
Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects 128
Convenient Synthesis of the Antibiotic Linezolid via an Oxazolidine-2,4-dione Intermediate Derived from the Chiral Building Block Isoserine 126
Integrin-targeting dye-doped peg-shell/silica-core nanoparticles mimicking the proapoptotic Smac/DIABLO protein 124
Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus 122
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 122
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics 119
The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists. 116
Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions 114
Synthesis and assay of retro-α4β1 integrin-targeting motifs 113
In-peptide synthesis of di-oxazolidinone and dehydroamino acid-oxazolidinone motifs as β-turn inducers 112
Controlled solid phase peptide bond formation using N-carboxyanhydrides and PEG resins in water. 110
Investigation of the Interaction Between the Atypical Agonist c[YpwFG] and MOR 107
Heterocyclic Scaffolds in the Design of Peptidomimetic Integrin Ligands: Synthetic Strategies, Structural Aspects, and Biological Activity 107
Cyclopeptide analogs for generating new molecular and 3D diversity 106
null 105
Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-d-alanine 101
Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold 101
NEW PEPTIDOMIMETIC α4β1-INTEGRIN ANTAGONISTS FOR REDUCING INFLAMMATION AND ALLERGIC REACTIONS 99
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 98
DETERMINATION OF THE BIOLOGICALLY ACTIVE STRUCTURE OF THE ATYPICAL MOR-LIGAND c[D-Asp-1-amide-beta-Ala-D-Trp-Phe] AND ANALOGUES BY NMR AND MOLECULAR DOCKING 95
null 93
Strategies to Improve Bioavailability and In Vivo Efficacy of the Endogenous Opioid Peptides Endomorphin-1 and Endomorphin-2 93
Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans 91
Interactions between atypical opioid agonists and MOR 91
Synthesis and Analysis of the Conformational Preferences of 5- Aminomethyloxazolidine-2,4-dione Scaffolds: First Examples of beta2- and beta2,2-Homo-Freidinger Lactam Analogues 90
Synthesis of Constrained Peptidomimetics Containing 2-Oxo-1,3-oxazolidine-4-carboxylic Acids 90
Synthesis and Conformational Analysis of Cyclotetrapeptide Mimetic beta-Turn Templates and Validation as 3D Scaffolds 90
Tryptophan-Containing Non-Cationizable Opioid Peptides - A new chemotype with unusual structure and in vivo activity 87
Development and characterization of Endomorphin-1 analogues as novel potential analgesic drugs. 84
Investigation on MOR receptor activation by atypical mechanisms 83
Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic 82
Expedient synthesis of pseudo-Pro-containing peptides: towards constrained peptidomimetics and foldamers 81
Synthesis of tripeptides containing D-Trp substituted at indole ring, and assessment of MOR affinity and in vivo central antinociception. 81
Dehydro-beta-amino acid containing peptidomimetics as integrin receptor ligands 80
Synthesis of beta2- and beta2,2-homo-Freidinger Lactam analogs, conformational analysis, and applications in Medicinal Chemistry 76
Nanostructured Materials for the Detection of Markers of Asthma and Other Correlated Inflammatory Diseases 72
Peptidomimetic probes for modulating α4β1 integrin activity 69
Peptidomimetic Scaffolds for the Discovery of New Bioactive Compounds. Cyclotetrapeptide Analogues Based on a 13-Membered, Partially Modified Retro-Inverso Structure. Applications to the synthesis of Cancer Cell Adhesion Inhibitors 69
Selective detection of α4β1 integrin (VLA-4)-expressing cells using peptide-functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites 69
One-step synthesis of constrained peptidomimetics including oxazolidinones and/or dehydro-amino acids, and application to the design of bioactive compounds 67
Opioid activity profiles of peptides containing overlapping portions of CJ-15,208 and CycloEM, and identification of the bioactive conformations 62
TRYptophan-COntaining Non-Cationizable Opioid PeptideS (TRYCONCOPS): A new paradigm for opioid peptides 58
Endomorphin-1 analogues as novel and highly selective MOPr agonists: design and characterization of innovative analgesic drugs 56
OPIOID RECEPTOR-TARGETING CYCLOPEPTIDES FOR PAIN MANAGEMENT: NEW STRUCTURES, NEW MECHANISMS 56
Hybrid alfa/beta-dipeptide scaffolds as inductors of constrained conformations 54
Trypoids, a novel group of mu-opioid receptor-selective di- and tri-peptides: design and characterization of novel analgesics 49
Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model 43
Peptide direct growth on poly(acrylic acid)/poly(vinyl alcohol) electrospun fibers coated with branched poly(ethylenimine): A solid-phase approach for scaffolds biofunctionalization 10
Totale 6.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.767
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.167 0 0 0 0 154 136 183 204 220 116 52 102
2020/2021880 175 53 45 42 19 48 60 62 95 40 43 198
2021/20221.158 171 89 54 42 126 60 37 127 41 55 160 196
2022/20231.188 108 180 52 172 98 95 38 59 212 22 104 48
2023/2024387 32 46 23 30 41 86 18 22 12 20 28 29
2024/2025725 46 233 141 97 208 0 0 0 0 0 0 0
Totale 6.455